P. Ridker

Use of Pharmacogenetic and Clinical Factors to Predict the Therapeutic Dose of Warfarin

M. Rieder, P. Ridker, R. Glynn, 2008, Clinical pharmacology and therapeutics.

ISIS-4: A randomised factorial trial assessing early oral captopril, oral mononitrate, and intravenous magnesium sulphate in 58 050 patients with suspected acute myocardial infarction

R. Collins, M. Keltai, B. Lewis, 1995, The Lancet.

Increased inflammatory markers in children with familial hypercholesterolaemia

P. Ridker, N. Rifai, J. Kastelein, 2006, European journal of clinical investigation.

n g l a d r n a l of m e d i c i n e Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease

P. Libby, P. Pais, R. Glynn, 2017 .

A polymorphism in the VKORC 1-regulator calumenin predicts higher warfarin doses in African-Americans

D. Voora, E. Deych, B. Gage, 2010 .

ISIS-4: A randomised factorial trial assessing early oral captopril, oral mononitrate, and intravenous magnesium sulphate in 58 050 patients with suspected acute myocardial infarction

Raymond C. Schneider, R. Collins, M. Keltai, 1995, The Lancet.

Ability of VKORC1 and CYP2C9 to predict therapeutic warfarin dose during the initial weeks of therapy

Jenine K. Harris, P. Ridker, R. Glynn, 2010, Journal of thrombosis and haemostasis : JTH.

Docosahexaenoic acid restores endothelial function in children with hyperlipidemia: results from the EARLY study.

P. Ridker, J. Morrow, N. Rifai, 2004, International journal of clinical pharmacology and therapeutics.

Migraine and Biomarkers of Cardiovascular Disease in Women

P. Ridker, J. Buring, T. Kurth, 2008, Cephalalgia : an international journal of headache.